108139
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
异丙嗪联合甲氧氯普胺预防腹腔镜结直肠癌手术患者术后恶心呕吐的随机对照试验
Authors Liu R, Bi R, Zhang J, Li X, Tian B, Yan W
Received 6 March 2025
Accepted for publication 17 September 2025
Published 4 October 2025 Volume 2025:19 Pages 9029—9039
DOI https://doi.org/10.2147/DDDT.S526724
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Anastasios Lymperopoulos
Ruijuan Liu,1 Ruirui Bi,2 Jiqiang Zhang,3 Xia Li,1 Bin Tian,1 Wenjun Yan1
1Department of Anesthesiology, Gansu Provincial Hospital, Lanzhou, 730000, People’s Republic of China; 2Department of Anesthesiology, Nanjing Drum Tower Hospital, Nanjing, 210008, People’s Republic of China; 3Department of Anesthesiology and Perioperative Medicine, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People’s Republic of China
Correspondence: Wenjun Yan, Department of Anesthesiology, Gansu Provincial Hospital, No. 204 Donggang West Road, Lanzhou, 730000, People’s Republic of China, Tel +86-13893370700, Email 13893370700@163.com
Purpose: Postoperative nausea and vomiting (PONV) are undesirable postoperative problems in patients undergoing surgery. However, there is currently no satisfactory solution to this problem.
Patients and Methods: This prospective, single-center, randomized, double-blind, pilot study was conducted at Gansu Provincial Hospital in China. Patients aged 18– 65 years who underwent elective colorectal tumor resection were randomly assigned to receive 6.25 mg promethazine or 1 mL saline intravenously before induction of anesthesia. All patients then received postoperative patient-controlled intravenous analgesia and a continuous metoclopramide infusion at 50 mg. The primary endpoint was the incidence and severity of PONV at 6 h, 24 h, 48 h, and 72 h postoperatively.
Results: Between June 2021 and March 2022, 96 eligible patients were included in the final analysis, with 48 patients in the promethazine group and 46 in the saline group. The incidence and severity of nausea during the early period (the first 6 hours postoperatively) were significantly different between groups (P = 0.031 and P = 0.036). A statistically significant difference was found in the incidence and severity within 24 hours postoperatively (P = 0.023 and P = 0.020). The incidence and severity of vomiting were significantly different between groups at 6 h postoperatively (P = 0.043 and P = 0.048). Vomiting incidence and severity were statistically different during the 24 hours postoperatively (P = 0.012 and P = 0.046). A significant statistical difference was found in the satisfaction between the two groups during the postoperative observation period (P = 0.004).
Conclusion: Preoperative prophylactic promethazine significantly reduced the incidence and severity of PONV within 24 hours postoperatively, with few adverse effects and no serious adverse reactions. Additionally, patient satisfaction was also improved.
Keywords: promethazine, colorectal tumor, laparoscopic surgery, nausea, vomiting
1Department of Anesthesiology, Gansu Provincial Hospital, Lanzhou, 730000, People’s Republic of China; 2Department of Anesthesiology, Nanjing Drum Tower Hospital, Nanjing, 210008, People’s Republic of China; 3Department of Anesthesiology and Perioperative Medicine, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People’s Republic of China
Correspondence: Wenjun Yan, Department of Anesthesiology, Gansu Provincial Hospital, No. 204 Donggang West Road, Lanzhou, 730000, People’s Republic of China, Tel +86-13893370700, Email 13893370700@163.com
Purpose: Postoperative nausea and vomiting (PONV) are undesirable postoperative problems in patients undergoing surgery. However, there is currently no satisfactory solution to this problem.
Patients and Methods: This prospective, single-center, randomized, double-blind, pilot study was conducted at Gansu Provincial Hospital in China. Patients aged 18– 65 years who underwent elective colorectal tumor resection were randomly assigned to receive 6.25 mg promethazine or 1 mL saline intravenously before induction of anesthesia. All patients then received postoperative patient-controlled intravenous analgesia and a continuous metoclopramide infusion at 50 mg. The primary endpoint was the incidence and severity of PONV at 6 h, 24 h, 48 h, and 72 h postoperatively.
Results: Between June 2021 and March 2022, 96 eligible patients were included in the final analysis, with 48 patients in the promethazine group and 46 in the saline group. The incidence and severity of nausea during the early period (the first 6 hours postoperatively) were significantly different between groups (P = 0.031 and P = 0.036). A statistically significant difference was found in the incidence and severity within 24 hours postoperatively (P = 0.023 and P = 0.020). The incidence and severity of vomiting were significantly different between groups at 6 h postoperatively (P = 0.043 and P = 0.048). Vomiting incidence and severity were statistically different during the 24 hours postoperatively (P = 0.012 and P = 0.046). A significant statistical difference was found in the satisfaction between the two groups during the postoperative observation period (P = 0.004).
Conclusion: Preoperative prophylactic promethazine significantly reduced the incidence and severity of PONV within 24 hours postoperatively, with few adverse effects and no serious adverse reactions. Additionally, patient satisfaction was also improved.
Keywords: promethazine, colorectal tumor, laparoscopic surgery, nausea, vomiting